コンテンツへスキップ
Merck

D-915

Supelco

デスアルキルフルラゼパム 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
C15H10ClFN2O
CAS番号:
分子量:
288.70
EC Number:
UNSPSCコード:
41116107
NACRES:
NA.24

グレード

certified reference material

品質水準

形状

liquid

特徴

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

メーカー/製品名

Cerilliant®

drug control

Narcotic Licence Schedule B (Switzerland)

濃度

1.0 mg/mL in methanol

テクニック

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

アプリケーション

clinical testing

フォーマット

single component solution

保管温度

−20°C

SMILES記法

Fc1ccccc1C2=NCC(=O)Nc3ccc(Cl)cc23

InChI

1S/C15H10ClFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)

InChI Key

UVCOILFBWYKHHB-UHFFFAOYSA-N

詳細

Desalkylflurazepam, also known as N-desalkyl-2-oxoquazepam, is a long-acting metabolite of the benzodiazepine drug flurazepam. Flurazepam is sold unde the trade names Dalmane and Dalmadorm for the treatment of mild to moderate insomnia. This Certified Spiking Solution® is suited for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis or urine drug testing.

アプリケーション


  • Pharmacokinetic profiling: Research on flurazepam metabolites, including Desalkylflurazepam, utilizes high-performance liquid chromatography for detailed pharmacokinetic studies in rats, providing essential data for understanding drug behavior and metabolism (Lau et al., 1987).

  • Neuroscience tool: Desalkylflurazepam is applied in neuroscience research to understand the dynamics of benzodiazepine binding on living cells, utilizing small ligands in fluorescence correlation spectroscopy, a method pivotal for real-time molecular interactions study (Hegener et al., 2002).

  • Drug testing applications: The compound is used in the development of analytical techniques like ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS/MS) for the detection of benzodiazepines in hair, useful in workplace drug testing and forensic science (Ramírez Fernández et al., 2015).

  • Toxicological analysis: Desalkylflurazepam serves as a reference standard in forensic toxicology to facilitate the rapid determination of benzodiazepines and their metabolites in biological samples, crucial for accurate and swift diagnostic purposes (Jeong et al., 2015).

  • Immunosorbent assay applications: This benzodiazepine metabolite is instrumental in examining cross-reactivity of psychoactive substances in enzyme-linked immunosorbent assay (ELISA) techniques, enhancing drug testing capabilities in clinical settings (Cieri et al., 2024).

法的情報

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

ピクトグラム

FlameSkull and crossbonesHealth hazard

シグナルワード

Danger

危険有害性情報

危険有害性の分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

ターゲットの組織

Eyes,Central nervous system

保管分類コード

3 - Flammable liquids

WGK

WGK 2

引火点(°F)

49.5 °F - closed cup

引火点(℃)

9.7 °C - closed cup


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

消防法

第4類:引火性液体
アルコール類
危険等級II

労働安全衛生法名称等を表示すべき危険物及び有害物

名称等を表示すべき危険物及び有害物

労働安全衛生法名称等を通知すべき危険物及び有害物

名称等を通知すべき危険物及び有害物

Jan Code

D-915-CC:
D-915-1ML:4548173316499


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

N Zampaglione et al.
Drug metabolism and disposition: the biological fate of chemicals, 13(1), 25-29 (1985-01-01)
The absorption, metabolism, and excretion of quazepam, a new benzodiazepine hypnotic, was investigated in six normal male volunteers after oral administration of 25 mg 14C-quazepam in solution. Quazepam was well absorbed. Plasma radioactivity peaked (324.6 ng quazepam eq/ml) 1.75 hr
W Sieghart
Neuroscience letters, 38(1), 73-78 (1983-07-15)
The potency of several new benzodiazepines as inhibitors of [3H]flunitrazepam binding was investigated in membranes from rat cerebellum or hippocampus. It was found that quazepam and two of its metabolites have a higher affinity for benzodiazepine receptors in cerebellum than
Kimiyasu Kato et al.
Therapeutic drug monitoring, 25(4), 473-477 (2003-07-29)
The effects of itraconazole, a potent inhibitor of cytochrome P450 (CYP) 3A4, on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug were studied. Ten healthy male volunteers received itraconazole 100
[Pharmacokinetics of the two major metabolites of ethyl loflazepate (CM6912) in dogs and humans. Simulation by a digital computer].
M Ito et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 106(8), 703-708 (1986-08-01)
H Morishita et al.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 86(1), 71-85 (1985-07-01)
Pharmacodynamic effects of ethyl 7-chloro-2,3-dihydro-5-(2-fluorophenyl)-2-oxo-1H-1,4- benzodiazepine-3-carboxylate (CM6912), a new benzodiazepine derivative, and its main metabolites (CM6913 = M1, CM7116 = M2) on the peripheral systems were investigated in several species of animals. In pentobarbital-anesthetized rabbits, CM6912 and M2 (1 or

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)